Jane Street’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-65,200
Closed -$72K 11210
2021
Q4
$72K Sell
65,200
-91,300
-58% -$141K ﹤0.01% 9386
2021
Q3
$290K Sell
156,500
-78,000
-33% -$175K ﹤0.01% 8259
2021
Q2
$743K Sell
234,500
-64,700
-22% -$162K ﹤0.01% 6469
2021
Q1
$972K Buy
+299,200
New +$1.08M ﹤0.01% 5510
2018
Q3
Sell
-11,108
Closed -$630K 5840
2018
Q2
$630K Buy
+11,108
New +$405K ﹤0.01% 3326

Other funds holding ASXC

Jane Street's ASXC Position: Q3 2024 in Review

Jane Street sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 489,252 shares — an estimated $163K sold.

Jane Street first reported a position in ASXC in Q3 2017 and held it in 20 quarters. The position peaked at $1.42M in Q1 2021. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Jane Street reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Jane Street sold 489,252 Asensus Surgical, Inc. shares in Q3 2024, an estimated $163K.
  • Jane Street first reported a position in Asensus Surgical, Inc. in Q3 2017 and held it in 20 quarters.
  • Jane Street's Asensus Surgical, Inc. position peaked at $1.42M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.